Melanoma Immunotherapy and Precision Medicine in the Era of Tumor Micro-Tissue Engineering: Where Are We Now and Where Are We Going?
Introduction Melanoma is clearly a complex disease with a high degree of heterogeneity and adaptability. Melanoma
Get a better understanding and prediction for pre-clinical drug trials
Allowing comprehension and predicting of human responses earlier, while also offering ethical alternatives to animal testing.
Introduction Melanoma is clearly a complex disease with a high degree of heterogeneity and adaptability. Melanoma
Introduction The gut-liver axis is the bidirectional interaction that exists between the gut and its microbiota,
Introduction Microfluidic 3D Endothelium-on-a-Chip – The endothelium is a thin membrane that lines the heart and
Introduction The phrase ‘vascular niche’ refers to a region rich in blood arteries where endothelial cells
Abstract (Ramadan et al) : Improved in vitro models of human organs for predicting drug efficacy, interactions, and
Breast Biopsies and Breast Cancer Breast cancer is the most common female cancer worldwide with the
Organs-on-Chip for Drug Development A drug should pass the preclinical evaluation phase to be FDA-approved. This
Immune Checkpoint Modulators as an emerging therapy Through this paper, Kim and colleagues highlight the way
Immune checkpoint modulation in renal cell carcinoma In this paper, Bedke and colleague highlight the way that patients treated for
Immune Checkpoint Modulators Summary Immune Checkpoint modulators are new promising therapies that specifically target the ability
14 rue de la Beaune,
93100 Montreuil (Paris)
France
+33 9 87 04 70 35
contact@cherrybiotech.com